Hemostemix Inc. (HEM.V)
Develops blood stem cell treatments for blood vessel and heart diseases
0.07+0.17%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-30.0%
The outlook
HEM.V is trading near the lower end of its 52-week range, with price action mixed relative to moving averages. Analyst coverage appears thin or unavailable. The overall sentiment leans bearish based on current market data.
What’s behind the score
Price trendMixed vs its moving averages
52-week range30% of the way from its 52-week low to high
Market cap
$14.3M
52-wk high
0.14
52-wk low
0.04
50-day avg
0.06
200-day avg
0.08
Trailing P/E
—